Biolog Inc.

Hayward, CA, United States

Biolog Inc.

Hayward, CA, United States
SEARCH FILTERS
Time filter
Source Type

The report on global RFID Blood Monitoring Systemmarket is a comprehensive study of demand, market size, forecasts, trends and factors affecting the global RFID Blood Monitoring Systemmarket. Moreover, the report is collective presentation of primary and secondary research findings. In addition, it provides deep insights on the factors that driving, restraining the global RFID Blood Monitoring System market. Porter's five forces model in the report provides insights into the competitive rivalry in the global RFID Blood Monitoring Systemmarket over the period of 2015 – 2023. Further, IGR- Growth Matrix given in the report brings an insight on the investment areas that existing or new market players can consider. Research methodology • Primary Research Our primary research involves extensive interviews and analysis of the opinions provided by the primary respondents. The primary research starts with identifying and approaching the primary respondents, the primary respondents are approached through 1. Key Opinion Leaders associated with Infinium Global Research 2. Internal and External subject matter experts 3. Professionals and participants from LinkedIn, Hoovers, Factiva and Bloggers Our primary research respondents typically include 1. Executives working with leading companies in the market under review 2. Product/brand/marketing managers 3. CXO level executives 4. Regional/zonal/ country managers 5. Vice President level executives. • Secondary Research Secondary research involves extensive exploring through the secondary sources of information available in both public domain and paid sources. At Infinium Global Research, each research study is based on over 500 hours of secondary research accompanied by primary research. The information obtained through the secondary sources is validated through the crosscheck on various data sources. The secondary sources of the data typically include • Company reports and publications • Government/institutional publications • Trade and associations' journals • Databases such as WTO, OECD, and World Bank, among others. • Websites and publications by research agencies Report Findings 1) Drivers • Increasing awareness among hospitals and blood banks in RFID enabled blood storage • Increasing incidence of chronic disease • Rising blood transfusions 2) Restraints • Stringent government regulations • High initial cost associated with the installation and maintenance of RFID systems 3) Opportunities • Increase in R&D activities regarding RFID systems • Growing adoption of RFID based solutions Segments Covered 1) Global RFID Blood Monitoring System market by Product types a. Systems b. Tags 2) Global RFID Blood Monitoring System market by End Users a. Blood Banks b. Hospital Blood Centres Companies profiled: The companies covered in the report include o Biolog-id o Mediware Information System o Honeywell o Nordic ID o TAGSY RFID o Zebra Technologies Wave Mark o Log Tag o Terso Solutions o RFID Group o Solstice Medical LLC o Stanley Innerspace o Logi Tag and Mobile Aspects Inc. o Magellan Technologies o SATO Vicinity. Reasons to buy this report 1) Comprehensive analysis of global as well as regional markets of RFID Blood Monitoring System 2) Complete coverage of all the product type and applications segments to analyze the trends, developments in RFID Blood Monitoring Systemmarket, and forecast of market size up to 2023. 3) Comprehensive analysis of the companies operating in RFID Blood Monitoring Systemmarket. The company profile includes analysis of product portfolio, revenue, SWOT analysis and latest developments of the company. 4) Infinium Global Research- Growth Matrix presents analysis of the product segments and geographies that market players should focus to invest, consolidate, expand and/or diversify. Read the full report: http://www.reportlinker.com/p04947556/RFID-Blood-Monitoring-System-Market-Global-Industry-Analysis-Trends-Market-Size-Forecasts-to.html About Reportlinker ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place. http://www.reportlinker.com


Dublin, July 20, 2017 (GLOBE NEWSWIRE) -- The "Chitin and Chitosan Derivatives: Technologies, Applications and Global Markets" report has been added to Research and Markets' offering. The Global Chitin and Chitosan Market Should Reach $4.2 Billion by 2021 from $2.0 Billion in 2016 at a CAGR of 15.4% Chitin and chitosan derivatives are naturally occurring polymers with a wide range of applications. Due to the wide availability of the raw material used to obtain chitin and chitosan derivatives, demand for these products has increased recently. To provide a better understanding of the market, the market is segmented on the basis of product and application. Major products included in the report are chitin, chitosan, glucosamine and other derivatives. The application markets covered in the report are healthcare, biotechnology, animal food, agriculture, water treatment, food and beverage and water treatment. The report also covers the subsegments and related markets of the application markets above. The raw materials and key technologies used in the chitin and chitosan derivatives market are also covered at length. All of the product and application markets are further segmented by geographic region. The major geographic regions covered in the report are North America, South America, Europe, Asia-Pacific and the rest of the world (RoW), which includes Morocco, Egypt, South Africa and other African countries. A country-specific breakdown of the market for chitin and chitosan derivatives is also included in the report. Estimated values used are based on manufacturers' total revenues. The study covers the global market for chitin and chitosan derivatives and is not limited to the countries included in this report. The selection of the countries to be included in this report was mainly based on the total revenue generated from the sale of chitin and chitosan derivatives. The competitive landscape of the global market for chitin and chitosan derivatives is discussed and includes profiles of the major companies and their product portfolios. All categories are discussed in detail, describing each segment, identifying current products on the market, measuring market size, identifying market drivers, forecasting for 2016 to 2021 and assessing the competitors and competitor market shares. Report Includes - An overview of the chitin and chitosan derivatives market. - Analyses of global market trends, with data from 2015, 2016 and projections of compound annual growth rates (CAGRs) through 2021. - Segmentation of the market on the basis of products, applications and region. - In-depth coverage of the market dynamics, technology trends, drivers, constraints, and key strategies. - A look at key innovation in chitin and chitosan markets and discussion of applications of chitin and chitosan derivatives. - Profiles of major players in the industry. Key Topics Covered: 1: Introduction 2: Summary - Chitin And Chitosan: History And Current Market Trend 3: Overview - Key Drivers Of The Chitin And Chitosan Market - Key Market Restraints - Opportunities - Regulations 4: Market By Product - Chitin - Chitosan - Glucosamine - Others 5: Market By Industry Application - Healthcare - Biotechnology - Animal Food - Agriculture - Water Treatment - Food And Beverages - Personal Care Products 6: Regional Market Analysis 7: Company Profiles - Advanced Biopolymers AS - Agratech International Inc. - Bio21 - Biolog Heppe GMBH - Biophrame Technologies - Cargill Inc. - Chitosanlab - Dainichiseika Color & Chemicals Mfg. Co. Ltd. - Fengrun Biochemical Co. Ltd. - Fmc Health And Nutrition - France Chitine - Golden-Shell Pharmaceutical Co. Ltd. - GTC Bio Corp. - Heppe Medical Chitosan Gmbh - Jiangsu Aoxin Biotechnology Co. Ltd. - Kawaken Fine Chemicals Co. Ltd. - Kiomed Pharma - Kitozyme S.A. - Kunpoong Bio Co. Ltd. - Mahtani India Pvt. Ltd. - Marshall Marine Products - Meron Biopolymers - Nano3Bio - Novamatrix - Panvo Organics Pvt. Ltd. - Pelican Biotech & Chemicals Labs Pvt. Ltd. - Primex EHF - Prospec - PT Biotech Surindo - Shrividya Enterprises - Thahira Chemicals - TSI Group Ltd. - Vietnam Food (VNF) - Wellmune - Wisapple Biotech - Xianju Tengwang Chitosan Factory - Yang Zhou Rixing Biotech Co. Ltd. - Zhejiang Aoxing Biotechnology Co. Ltd. - Zhengzhou Kaibang Biotechnology Co. Ltd. For more information about this report visit https://www.researchandmarkets.com/research/3k3prh/chitin_and


The survey is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the automated microbiology market during the next five years. The report examines key trends; reviews current and emerging assays; analyzes potential applications of innovative diagnostic technologies; forecasts volume and sales for 100 molecular diagnostic, microbial identification, antibiotic susceptibility, blood culture, urine screening and immunodiagnostic procedures; profiles leading players and potential market entrants; and suggests alternative business expansion strategies for suppliers. The level of automation in the microbiology laboratory has been lagging behind that of other major clinical laboratory segments, such as chemistry and hematology. The slow acceptance of the technology is in part due to the complexity of developing automation suitable for microbiology tests. The introduction of automated microbiology instrumentation has been delayed by a number of intrinsic and technical problems. The diffusion of automated microbiology systems, once the technology was developed, has not matched that of other automated laboratory technologies. The acquisition of automation in microbiology has been slowed by forces less easily identifiable than the effects of various reimbursement plans. Some laboratorians still believe that current instrumentation is not the ultimate technology and expect better automation on the horizon. The driving force behind the need for rapid reporting of microbiological test results is the clinical relevance in a time of financial austerity, a time when cost and health care effectiveness to the patient and diagnostician looms ever larger, and where after-the-fact results at high expense are coming under severe scrutiny worldwide. This comprehensive 7-country survey will assist diagnostics industry executives, as well as companies planning to diversify into the dynamic and rapidly expanding microbiology market, in evaluating emerging opportunities and developing effective business strategies. - Review of major automated molecular diagnostic, multipurpose, specialized, microbial identification, antibiotic susceptibility, blood culture, urine screening, and immunodiagnostic analyzers marketed by Abbott, Alifax, Anagen, BD, Beckman Coulter/Danaher, Biochem, Biolog, bioMerieux, Bio-Rad, Biotrol, Cepheid, Curetis, GenMark, Hologic/Gen-Probe, HTG, Iris, J&J, Labsystems, Life Technologies, MiDI, Olympus, Qiagen, Roche, Siemens, Sy-Lab, Sysmex, Tecan, Thermo Fisher, Tosoh and other suppliers. - Assessment of molecular diagnostic, monoclonal antibody, immunoassay, and other technologies and their potential applications for the microbiology market. - Strategic assessments of major suppliers and emerging market entrants, including their sales, product portfolios, marketing tactics, collaborative arrangements and new products in R&D. - Emerging opportunities for new analyzers, reagents kits, IT and other products with significant market appeal during the next five years. - Potential market entry barriers and risks. Read the full report: http://www.reportlinker.com/p04933627/Latin-America-Automated-Microbiology-Market-A-7-Country-Analysis-Supplier-Strategies-Volume-and-Sales-Forecasts-for-100-Molecular-Diagnostic-Microbial-Identification.html About Reportlinker ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place. http://www.reportlinker.com   __________________________ Contact Clare: clare@reportlinker.com US: (339)-368-6001 Intl: +1 339-368-6001 To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/latin-america-automated-microbiology-market-2021-a-7-country-analysis--supplier-strategies-volume-and-sales-forecasts-for-100-molecular-diagnostic-microbial-identification-300470303.html


The survey is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the automated microbiology market during the next five years. The report examines key trends; reviews current and emerging assays; analyzes potential applications of innovative diagnostic technologies; forecasts volume and sales for 100 molecular diagnostic, microbial identification, antibiotic susceptibility, blood culture, urine screening and immunodiagnostic procedures; profiles leading players and potential market entrants; and suggests alternative business expansion strategies for suppliers. The level of automation in the microbiology laboratory has been lagging behind that of other major clinical laboratory segments, such as chemistry and hematology. The slow acceptance of the technology is in part due to the complexity of developing automation suitable for microbiology tests. The introduction of automated microbiology instrumentation has been delayed by a number of intrinsic and technical problems. The diffusion of automated microbiology systems, once the technology was developed, has not matched that of other automated laboratory technologies. The acquisition of automation in microbiology has been slowed by forces less easily identifiable than the effects of various reimbursement plans. Some laboratorians still believe that current instrumentation is not the ultimate technology and expect better automation on the horizon. The driving force behind the need for rapid reporting of microbiological test results is the clinical relevance in a time of financial austerity, a time when cost and health care effectiveness to the patient and diagnostician looms ever larger, and where after-the-fact results at high expense are coming under severe scrutiny worldwide. This comprehensive 3-country survey will assist diagnostics industry executives, as well as companies planning to diversify into the dynamic and rapidly expanding microbiology market, in evaluating emerging opportunities and developing effective business strategies. - Review of major automated molecular diagnostic, multipurpose, specialized, microbial identification, antibiotic susceptibility, blood culture, urine screening, and immunodiagnostic analyzers marketed by Abbott, Alifax, Anagen, BD, Beckman Coulter/Danaher, Biochem, Biolog, bioMerieux, Bio-Rad, Biotrol, Cepheid, Curetis, GenMark, Hologic/Gen-Probe, HTG, Iris, J&J, Labsystems, Life Technologies, MiDI, Olympus, Qiagen, Roche, Siemens, Sy-Lab, Sysmex, Tecan, Thermo Fisher, Tosoh and other suppliers. - Assessment of molecular diagnostic, monoclonal antibody, immunoassay, and other technologies and their potential applications for the microbiology market. - Strategic assessments of major suppliers and emerging market entrants, including their sales, product portfolios, marketing tactics, collaborative arrangements and new products in R&D. - Emerging opportunities for new analyzers, reagents kits, IT and other products with significant market appeal during the next five years. - Potential market entry barriers and risks. Download the full report: https://www.reportbuyer.com/product/4933629/ About Reportbuyer Reportbuyer is a leading industry intelligence solution that provides all market research reports from top publishers http://www.reportbuyer.com For more information: Sarah Smith Research Advisor at Reportbuyer.com Email: query@reportbuyer.com Tel: +44 208 816 85 48 Website: www.reportbuyer.com To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/north-america-automated-microbiology-market-2021-usa-canada-mexico--supplier-shares-and-strategies-volume-and-sales-segment-forecasts-for-100-molecular-diagnostic-microbial-identification-300469516.html


NEW YORK, Sept. 26, 2017 /PRNewswire/ -- Read the full report: https://www.reportlinker.com/p05117900 The microbial identification market is expected to reach USD 3.00 billion by 2022 from USD 2.18 billion in 2017, at a CAGR of 6.6%. Factors driving the growth of this market include the increasing prevalence of infectious diseases, technological advancements in microbial identification, increasing food safety concerns, and government initiatives to promote use of microbial identification. On the other hand, the high cost of automated microbial identification systems is expected to limit market growth in the coming years. Complex regulatory frameworks that delay the approval of new microbial diagnostic tests are also expected to challenge market growth to a certain extent. "Consumables segment expected to grow at the fastest rate during the forecast period" The consumables used for microbial identification are anticipated to grow at the highest CAGR during the forecast. The need of consumables in large numbers as compared to instruments is the primary factor responsible for this positive market growth. "The diagnostic applications segment is anticipated to grow at the fastest growth rate during the forecast period" The microbial identification market by application, is categorized into diagnostic applications (human disease diagnosis and animal disease diagnosis), food testing, beverage testing, cosmetics and personal care products testing, pharmaceutical applications, environmental applications, and other applications. The diagnostic applications segment is estimated to grow at the fastest rate during the forecast period. Increasing use of microbial identification for the diagnosis of infectious diseases in humans and animals is the key factor driving the growth of this market. "The proteomics-based methods segment is estimated to grow at a rapid rate during the analysis period" By method, the microbial identification market is segmented into phenotypic, genotypic, and proteomics-based methods. The proteomics-based methods segment is the fastest growing segment of the global microbial identification market on the basis of method. The rising demand for proteomics-based methods on account of greater levels of sensitivity, accuracy, and specificity is driving the demand for this segment. "Asia is estimated to grow at the highest CAGR during the study period" Geographically, the microbial identification market is dominated by North America, followed by Europe in 2017. Asia is estimated to grow at the fastest rate which can be attributed to developing healthcare infrastructure, rising burden of infectious diseases, and increasing initiatives to promote the use of novel technologies for microbial identification. The primary interviews conducted for this report can be categorized as follows: • By Company Type - Tier 1 – 70% and Tier 2 – 30% • By Designation – C level – 62%, Director level – 21%, Others – 17% • By Region – North America – 50%, Europe – 20%, Asia– 30% The key players in the microbial identification market include Becton, Dickinson and Company (US), Thermo Fisher Scientific Inc. (US), Danaher Corporation (US), bioMérieux S.A. (France), Merck KGaA (Germany), Charles River Laboratories International, Inc. (US), Bruker Corporation (US), Shimadzu Corporation (Japan), VWR Corporation (US), Eurofins Scientific S.E. (Luxembourg), GTCR, LLC. (US), QIAGEN N.V. (Netherlands), Liofilchem s.r.l. (Italy), IEH Laboratories & Consulting Group (US), Alcami Corporation (US), Biolog, Inc. (US), Abellon CleanEnergy Limited (India), Alpha Analytical, Inc. (US), NeoGenomics, Inc. (US), Trivitron Healthcare (India), Molzym GmbH & Co. KG (Germany), Dynatec Labs (US), Altogen Labs (US), STERIS plc (UK), and Wickham Laboratories Ltd. (UK). Research Coverage: The report analyses the microbial identification market by product and service, method, application, end user, and region. Apart from a comprehensive geographic product analysis and market sizing, the report also provides a competitive landscape that covers the growth strategies adopted by industry players over the last three years. In addition, the company profiles include the product portfolios, developments, and strategies adopted by prominent market players to maintain and increase their shares in the market. Market research data, current market size, and forecast of the future trends will help key market players and new entrants to make the necessary decisions regarding product offerings, geographic focus, change in strategic approach, and levels of output in order to remain successful in the type, products, applications, end users, and regions. Key benefits of buying the Report: This report will enable both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn will help these firms garner greater market shares. Firms purchasing the report can use any one or a combination of the below-mentioned five strategies for strengthening their market shares. The report provides insights on the following pointers: • Market Penetration: Comprehensive information on the product portfolios of the top players in the microbial identification market • Product Development/Innovation: Detailed insights on the upcoming technologies, R&D activities, and product launches in the microbial identification market • Competitive Assessment: In-depth assessment of the market strategies, geographic and business segments, and product portfolios of the leading players in the microbial identification market • Market Development: Comprehensive information about emerging markets. This report analyzes the market for various microbial identification products and services across geographies • Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the microbial identification market Read the full report: https://www.reportlinker.com/p05117900 About Reportlinker ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place. https://www.reportlinker.com   __________________________ Contact Clare: clare@reportlinker.com   US: (339)-368-6001 Intl: +1 339-368-6001


News Article | September 19, 2017
Site: www.prnewswire.co.uk

Browse 184 Market Data Tables and 38 Figures spread through 227 Pages and in-depth TOC on "Microbial Identification Market" Early buyers will receive 10% customization on this report Factors driving the growth of this market include increasing incidence of infectious diseases coupled with epidemic and pandemic outbreaks, growing concerns about food safety, innovations in microbial identification techniques, and government initiatives and funding supporting microbial identification. Instruments are estimated to account for the largest market share in 2017 On the basis of product and service, the Microbial Identification Market is classified into instruments, consumables, and services. The instruments are expected to lead the global Microbial Identification Market in 2017. Factors driving the growth of this segment include the wide use of instruments across applications and technological advancements, which have led to the launch of innovative products. The phenotypic methods segment is estimated to dominate the market in 2017 By method, the market is segmented into phenotypic, genotypic, and proteomics-based methods. The phenotypic methods segment is anticipated to account for the largest share of the global Microbial Identification Market in 2017. These methods are cost-effective, easy to perform, and can deliver results rapidly. Therefore, they are widely adopted across industries, which is a major factor responsible for the large share of this segment. By end user, the hospitals, diagnostic laboratories, and blood banks segment is estimated to command for the largest share of the market during the forecast period On the basis of end user, the Microbial Identification Market is categorized into hospitals, diagnostic laboratories, and blood banks; food manufacturing companies; beverage manufacturing companies; pharmaceutical companies and CROs; and other end users. The hospitals, diagnostic laboratories, and blood banks segment is estimated to account for the largest share of the global Microbial Identification Market in 2017. The heavy burden of different infectious diseases, along with periodic outbreaks of pandemic and epidemic diseases is the key factors driving the growth of this end user segment. North America is estimated to command the largest share of the market Based on region, the Microbial Identification Market is segmented into North America, Europe, Asia, and Rest of the World (RoW). North America is expected to dominate the Microbial Identification Market in 2017. This is attributed to factors like increasing adoption of microbial identification techniques for research purposes; rising prevalence of infectious diseases; growing incidence of foodborne infections, safety concerns; and technological advancements in microbial identification products in the region as compared to other regions. Key players in the Microbial Identification Market include Becton, Dickinson and Company (US), Thermo Fisher Scientific Inc. (US), Danaher Corporation (US), bioMérieux S.A. (France), Merck KGaA (Germany), Charles River Laboratories International, Inc. (US), Bruker Corporation (US), Shimadzu Corporation (Japan), VWR Corporation (US), Eurofins Scientific S.E. (Luxembourg), GTCR, LLC. (US), QIAGEN N.V. (Netherlands), Liofilchem s.r.l. (Italy), IEH Laboratories & Consulting Group (US), Alcami Corporation (US), Biolog, Inc. (US), Abellon CleanEnergy Limited (India), Alpha Analytical, Inc. (US), NeoGenomics, Inc. (US), Trivitron Healthcare (India), Molzym GmbH & Co. KG (Germany), Dynatec Labs (US), Altogen Labs (US), STERIS plc (UK), and Wickham Laboratories Ltd. (UK). Microbiological Testing of Water Market by Pathogen (Bacteria, Protozoa, Viruses), Water Type (Drinking & Bottled Water, Industrial Water), Type (Instruments, Test Kits & Reagents), Industry, and Region - Global Forecast to 2022 MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies' revenues. Currently servicing 5000 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions. Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model - GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve. MarketsandMarkets's flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets. Connect with us on LinkedIn @ http://www.linkedin.com/company/marketsandmarkets


News Article | September 19, 2017
Site: www.prnewswire.com

Browse 184 Market Data Tables and 38 Figures spread through 227 Pages and in-depth TOC on "Microbial Identification Market" Early buyers will receive 10% customization on this report Factors driving the growth of this market include increasing incidence of infectious diseases coupled with epidemic and pandemic outbreaks, growing concerns about food safety, innovations in microbial identification techniques, and government initiatives and funding supporting microbial identification. Instruments are estimated to account for the largest market share in 2017 On the basis of product and service, the Microbial Identification Market is classified into instruments, consumables, and services. The instruments are expected to lead the global Microbial Identification Market in 2017. Factors driving the growth of this segment include the wide use of instruments across applications and technological advancements, which have led to the launch of innovative products. The phenotypic methods segment is estimated to dominate the market in 2017 By method, the market is segmented into phenotypic, genotypic, and proteomics-based methods. The phenotypic methods segment is anticipated to account for the largest share of the global Microbial Identification Market in 2017. These methods are cost-effective, easy to perform, and can deliver results rapidly. Therefore, they are widely adopted across industries, which is a major factor responsible for the large share of this segment. By end user, the hospitals, diagnostic laboratories, and blood banks segment is estimated to command for the largest share of the market during the forecast period On the basis of end user, the Microbial Identification Market is categorized into hospitals, diagnostic laboratories, and blood banks; food manufacturing companies; beverage manufacturing companies; pharmaceutical companies and CROs; and other end users. The hospitals, diagnostic laboratories, and blood banks segment is estimated to account for the largest share of the global Microbial Identification Market in 2017. The heavy burden of different infectious diseases, along with periodic outbreaks of pandemic and epidemic diseases is the key factors driving the growth of this end user segment. North America is estimated to command the largest share of the market Based on region, the Microbial Identification Market is segmented into North America, Europe, Asia, and Rest of the World (RoW). North America is expected to dominate the Microbial Identification Market in 2017. This is attributed to factors like increasing adoption of microbial identification techniques for research purposes; rising prevalence of infectious diseases; growing incidence of foodborne infections, safety concerns; and technological advancements in microbial identification products in the region as compared to other regions. Key players in the Microbial Identification Market include Becton, Dickinson and Company (US), Thermo Fisher Scientific Inc. (US), Danaher Corporation (US), bioMérieux S.A. (France), Merck KGaA (Germany), Charles River Laboratories International, Inc. (US), Bruker Corporation (US), Shimadzu Corporation (Japan), VWR Corporation (US), Eurofins Scientific S.E. (Luxembourg), GTCR, LLC. (US), QIAGEN N.V. (Netherlands), Liofilchem s.r.l. (Italy), IEH Laboratories & Consulting Group (US), Alcami Corporation (US), Biolog, Inc. (US), Abellon CleanEnergy Limited (India), Alpha Analytical, Inc. (US), NeoGenomics, Inc. (US), Trivitron Healthcare (India), Molzym GmbH & Co. KG (Germany), Dynatec Labs (US), Altogen Labs (US), STERIS plc (UK), and Wickham Laboratories Ltd. (UK). Microbiological Testing of Water Market by Pathogen (Bacteria, Protozoa, Viruses), Water Type (Drinking & Bottled Water, Industrial Water), Type (Instruments, Test Kits & Reagents), Industry, and Region - Global Forecast to 2022 MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies' revenues. Currently servicing 5000 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions. Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model - GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve. MarketsandMarkets's flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets. Connect with us on LinkedIn @ http://www.linkedin.com/company/marketsandmarkets


News Article | November 8, 2016
Site: www.marketwired.com

HAYWARD, CA--(Marketwired - November 08, 2016) - Biolog, Inc., a leader in the field of High Resolution Cell Phenotyping, announced that it has expanded its team by adding two veterans of the life sciences tools space. In August, Biolog elected David Weber to its Board of Directors. David has over 35 years of commercial experience across the life sciences industry with companies such as Pharmacia Biotech, Amersham Biosciences, Chemdex, Stratagene, and Eksigent Technologies. Prior to its recent acquisition by Thermo Fisher Scientific, David served as Executive Vice President and Chief Commercial Officer for Affymetrix and was instrumental in the company's turnaround. Today, Biolog announces the appointment of Richard Mabe to the position of Vice President of Sales and Marketing. Richard has had an extensive career in the life sciences industry with companies such as DuPont, Amersham International, GE Healthcare, and Sequenom. Richard's long track record of success in building and developing commercial teams will have significant impact on Biolog's business. "I am confident that the appointment of two industry veterans like David and Richard will enhance our already successful business and position Biolog for rapid and sustained growth," said Barry Bochner Ph.D., Biolog's Chief Executive Officer. "I am thrilled to welcome them into Biolog." Biolog is embarking on the release of exciting new products in the areas of microbial identification and characterization, and human cell and mitochondrial analysis. This is triggering an expansion and focus on the company's commercial initiatives. Biolog is a privately-held company based in Hayward, CA, that continues to lead in the development of powerful new cell analysis tools for solving critical problems in biological, pharmaceutical, and biotechnological research and development. It is the world leader in phenotypic cell profiling. Biolog products are available worldwide, either directly from the company or through its extensive network of international distributors. Further information can be obtained at Biolog's website, www.biolog.com.


Toxin production is a central issue in the pathogenesis of Clostridium difficile and many other pathogenic microorganisms. Toxin synthesis is influenced by a variety of known and unknown factors of genetics, physiology, and environment. To facilitate the study of toxin production by C. difficile, we have developed a new, reliable, quantitative, and robust cell-based cytotoxicity assay. Then we combined this new assay with Phenotype MicroArrays (PM) technology which provides high throughput testing of culture conditions. This allowed us to quantitatively measure toxin production by C. difficile type strain ATCC 9689 under 768 culture conditions. The culture conditions include different carbon, nitrogen, phosphorus, and sulfur sources. Among these, 89 conditions produced strong toxin induction and 31 produced strong toxin repression. Strong toxin inducers included adenine, guanosine, arginine dipeptides, γ-D-Glu-Gly, methylamine, and others. Some leucine dipeptides and the triple-leucine tripeptide were among the strongest toxin repressors. While some results are consistent with previous observations, others are new observations that provide insights into toxin regulation and pathogenesis of C. difficile. Additionally, we have demonstrated that this combined assay technology can be applied broadly to a wide range of toxin producing microorganisms. This study is the first demonstration of simultaneous assessment of a large number of culture conditions influencing bacterial toxin production. The new functional cytotoxin quantitation method developed provides a valuable tool for studying toxigenic microorganisms and may also find applications in clinical and epidemiological research. © 2013 Lei, Bochner.


The present invention is related to compositions and methods to treat, ameliorate and/or prevent morbidity and/or mortality from microbial infections. In particular, bacterial infections that are associated with the production and release of bacterial toxins. For example, many Clostridia bacteria, such as Clostridium difficile, release toxins resulting in tissue and organ damage and death, even after antibiotic therapy that either reduces or eliminates the bacteria. In particular, various peptides, polypeptides, and proteins are disclosed herein that either inactivate Clostridium difficile toxin and/or reduce Clostridium difficile toxin production.

Loading Biolog Inc. collaborators
Loading Biolog Inc. collaborators